These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 11099249)

  • 61. Breaking the fibrinolytic speed limit with microwheel co-delivery of tissue plasminogen activator and plasminogen.
    Disharoon D; Trewyn BG; Herson PS; Marr DWM; Neeves KB
    J Thromb Haemost; 2022 Feb; 20(2):486-497. PubMed ID: 34882946
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Locally applied recombinant plasmin results in effective thrombolysis in a porcine model of arteriovenous graft thrombosis.
    Hoefer IE; Stroes ES; Pasterkamp G; Levi MM; Reekers JA; Verhagen HJ; Meijers JC; Humphries JE; Rotmans JI
    J Vasc Interv Radiol; 2009 Jul; 20(7):951-8. PubMed ID: 19481472
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Thrombolytic treatment with tissue-type plasminogen activator (t-PA) containing liposomes in rabbits: a comparison with free t-PA.
    Heeremans JL; Prevost R; Bekkers ME; Los P; Emeis JJ; Kluft C; Crommelin DJ
    Thromb Haemost; 1995 Mar; 73(3):488-94. PubMed ID: 7667833
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Effect of thromboxane synthase inhibition on the thrombolytic action of tissue-type plasminogen activator in a rabbit model of peripheral arterial thrombosis.
    Shebuski RJ; Storer BL; Fujita T
    Thromb Res; 1988 Dec; 52(5):381-92. PubMed ID: 3146820
    [TBL] [Abstract][Full Text] [Related]  

  • 65. A new drug delivery system for intravenous coronary thrombolysis with thrombus targeting and stealth activity recoverable by ultrasound.
    Kawata H; Uesugi Y; Soeda T; Takemoto Y; Sung JH; Umaki K; Kato K; Ogiwara K; Nogami K; Ishigami K; Horii M; Uemura S; Shima M; Tabata Y; Saito Y
    J Am Coll Cardiol; 2012 Dec; 60(24):2550-7. PubMed ID: 23158532
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Bridging intravenous-intra-arterial rescue strategy increases recanalization and the likelihood of a good outcome in nonresponder intravenous tissue plasminogen activator-treated patients: a case-control study.
    Rubiera M; Ribo M; Pagola J; Coscojuela P; Rodriguez-Luna D; Maisterra O; Ibarra B; Piñeiro S; Meler P; Romero FJ; Alvarez-Sabin J; Molina CA
    Stroke; 2011 Apr; 42(4):993-7. PubMed ID: 21372307
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Lys-plasminogen as an adjunct to local intra-arterial fibrinolysis for carotid territory stroke: laboratory and clinical findings.
    Freitag HJ; Becker VU; Thie A; Tilsner V; Philapitsch A; Schwarz HP; Webhof U; Müller A; Zeumer H
    Neuroradiology; 1996 Feb; 38(2):181-5. PubMed ID: 8692437
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Re: augmented experimental pulse-spray thrombolysis with tissue plasminogen activator, enabling dose reduction by one or more orders of magnitude.
    Roy S
    J Vasc Interv Radiol; 2001 Feb; 12(2):264-6. PubMed ID: 11265895
    [No Abstract]   [Full Text] [Related]  

  • 69. New variant of human tissue plasminogen activator (TPA) with enhanced efficacy and lower incidence of bleeding compared with recombinant human TPA.
    Benedict CR; Refino CJ; Keyt BA; Pakala R; Paoni NF; Thomas GR; Bennett WF
    Circulation; 1995 Nov; 92(10):3032-40. PubMed ID: 7586274
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Phlegmasia cerulea dolens: treatment by pulse-spray and infusion thrombolysis.
    Robinson DL; Teitelbaum GP
    AJR Am J Roentgenol; 1993 Jun; 160(6):1288-90. PubMed ID: 8498234
    [No Abstract]   [Full Text] [Related]  

  • 71. Ultrasound identification and lysis of clots.
    Alexandrov AV
    Stroke; 2004 Nov; 35(11 Suppl 1):2722-5. PubMed ID: 15375301
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Time-Dependent Thrombus Resolution After Tissue-Type Plasminogen Activator in Patients With Stroke and Mice.
    Kim YD; Nam HS; Kim SH; Kim EY; Song D; Kwon I; Yang SH; Lee K; Yoo J; Lee HS; Heo JH
    Stroke; 2015 Jul; 46(7):1877-82. PubMed ID: 25967573
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Tissue-type plasminogen activator gene targets thrombolysis in atriums.
    Gong Y; Wang F; Li X; Gao Z; Zhang K; Fan C; Liu X
    J Thromb Thrombolysis; 2010 Nov; 30(4):507-14. PubMed ID: 20924774
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Fibrin-specificity of a plasminogen activator affects the efficiency of fibrinolysis and responsiveness to ultrasound: comparison of nine plasminogen activators in vitro.
    Sakharov DV; Barrertt-Bergshoeff M; Hekkenberg RT; Rijken DC
    Thromb Haemost; 1999 Apr; 81(4):605-12. PubMed ID: 10235448
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Pharmacological effects of the spin trap agents N-t-butyl-phenylnitrone (PBN) and 2,2,6, 6-tetramethylpiperidine-N-oxyl (TEMPO) in a rabbit thromboembolic stroke model: combination studies with the thrombolytic tissue plasminogen activator.
    Lapchak PA; Chapman DF; Zivin JA
    Stroke; 2001 Jan; 32(1):147-53. PubMed ID: 11136930
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Extended deep vein and inferior vena cava thrombosis in a 15-year-old boy: successful lysis with recombinant tissue-type plasminogen activator 2 weeks after onset of symptoms.
    Rosenbaum T; Rammos S; Kniemeyer HW; Göbel U
    Eur J Pediatr; 1993 Dec; 152(12):978-80. PubMed ID: 8131815
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Thrombolytic therapy for the treatment of prosthetic heart valve thrombosis in pregnancy with low-dose, slow infusion of tissue-type plasminogen activator.
    Özkan M; Çakal B; Karakoyun S; Gürsoy OM; Çevik C; Kalçık M; Oğuz AE; Gündüz S; Astarcioglu MA; Aykan AÇ; Bayram Z; Biteker M; Kaynak E; Kahveci G; Duran NE; Yıldız M
    Circulation; 2013 Jul; 128(5):532-40. PubMed ID: 23812180
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Delivery of tissue plasminogen activator and streptokinase magnetic nanoparticles to target vascular diseases.
    Tadayon A; Jamshidi R; Esmaeili A
    Int J Pharm; 2015 Nov; 495(1):428-438. PubMed ID: 26363110
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Retrovirus-Mediated Transfection of the Tissue-type Plasminogen Activator Gene Results in Increased Thrombolysis of Blood Clots.
    Wu X; Gong Y; Ding X; Cheng G; Yan W; She X; Wang C; Li X
    Biochem Genet; 2019 Apr; 57(2):234-247. PubMed ID: 30218285
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Ultrasound-enhanced tissue plasminogen activator thrombolysis in an in vitro porcine clot model.
    Holland CK; Vaidya SS; Datta S; Coussios CC; Shaw GJ
    Thromb Res; 2008; 121(5):663-73. PubMed ID: 17854867
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.